EP2793933
TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2-SULFATASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.12.2012EP published:
17.4.2019EP application number:
12860231.5
EPO information:
European Patent Register
Max expiry date:
20.12.2032
Title:
TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2-SULFATASE
Timeline
Today
21.12.2012EP application
17.4.2019EP Publication
Owner
Name:
Shire Human Genetic Therapies, Inc.Address:
300 Shire Way, 02421, Lexington MA, US
Inventor
Name:
BARBIER, AnnAddress:
Lexington, MA, US
Name:
MCCAULEY, ThomasAddress:
Arlington, MA, US
Name:
RICHARD, Charles, W., IIIAddress:
Carlisle, MA, US
Priority
Number:
201161580027 PDate:
23.12.2011Country:
US
Number:
201261590797 PDate:
25.1.2012Country:
US
Number:
201261590804 PDate:
25.1.2012Country:
US
Number:
201261609173 PDate:
9.3.2012Country:
US
Number:
201261734365 PDate:
6.12.2012Country:
US
Classification
Categories:
A61K 38/46, A61P 3/00